Literature DB >> 2408646

Ranitidine does not potentiate mediator release from human lung in vitro.

J M Hughes, J P Seale, D M Temple.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408646      PMCID: PMC1463835          DOI: 10.1111/j.1365-2125.1985.tb02702.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  New drugs for peptic ulcer.

Authors:  D A Henry
Journal:  Med J Aust       Date:  1984-09-01       Impact factor: 7.738

2.  Lipoxygenase products modulate histamine release in human basophils.

Authors:  S P Peters; M I Siegel; A Kagey-Sobotka; L M Lichtenstein
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

3.  Effects of oral H1 and H2 receptor antagonists in asthma.

Authors:  J D Leopold; J P Hartley; A P Smith
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

4.  Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Br J Pharmacol       Date:  1981-01       Impact factor: 8.739

5.  Pharmacokinetics of the H2- receptor antagonist ranitidine in man.

Authors:  J J McNeil; G W Mihaly; A Anderson; A W Marshall; R A Smallwood; W J Louis
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

6.  Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists.

Authors:  J M Hughes; J P Seale; D M Temple
Journal:  Eur J Pharmacol       Date:  1983-11-25       Impact factor: 4.432

7.  The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation.

Authors:  L F Platshon; M Kaliner
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

8.  The effects of the H1 and H2 antihistamines on "allergic" histamine release and its inhibition by histamine.

Authors:  L M Lichtenstein; E Gillespie
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

  8 in total
  1 in total

Review 1.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.